Register
Login:
Share:
Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'


Avacta Share Chat (AVCT)



Share Price: 66.25Bid: 65.50Ask: 67.00Change: 0.00 (0.00%)No Movement on Avacta
Spread: 1.50Spread as %: 2.29%Open: 66.25High: 66.25Low: 66.25Yesterday’s Close: 66.25


Share Discussion for Avacta


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Wisheyedbortum
Posts: 635
Answer
Opinion:Strong Buy
Price:74.50
DD77
19 Dec '16
This is the second time that my wife and I have visited Avacta, the first being at Wetherby during the days of AX1 and Optim. Apart from being a brilliant scientist, Dr. Smith is also a really nice guy and he went to great lengths to explain what the Affimers are capable of, where they could be used and how they are produced. Dr. Amrik Basran took us on a guided tour of the facility, which is full of brand new equipment, and explained the rudiments of affimer production. The main reason for our visit was to try to ascertain what all this means in terms of income and the share price and whether FinnCap's prediction of the SP at least doubling over the next 12 months was feasable, and the only way to do this was to talk to the CEO. With the information that I was given I came to the conclusion that Avacta has the potential to earn staggering amounts of money, but it just takes time to get the product out there to the big pharmas, get the licenses agreed and get the royalties rolling in.
 
DD77
Posts: 298
Off Topic
Opinion:No Opinion
Price:74.50
RE: Meeting.
19 Dec '16
Thanks Wisheyedbortum, useful info, id thought about topping up here too. Out of interest, why were you meeting Alastair Smith and viewing the facilities?
Trader4Pay
Posts: 57
Off Topic
Opinion:No Opinion
Price:74.00
RE: Meeting.
16 Dec '16
Thanks for the update Wisheye
Wisheyedbortum
Posts: 635
Observation
Opinion:Strong Buy
Price:74.00
Meeting.
16 Dec '16
Yesterday I had a most enjoyable and informative meeting with Dr. Alastair Smith. He is as mystified as the rest of us as to the ridiculously low share price which in no way represents the potential of Avacta. I had a quick tour of the new Cambridge facility which is impressive to say the least, but my main aim was to find out if the FinnCap prediction of "at least doubling of the SP over the next year" was indeed feasible. According to Dr. Smith, it certainly is. The major problem for the SP is that the partnerships that have been announced over the past few years are with companies that are relatively small and don't mind their names being made public. However, this group of partners is only the tip of the iceberg. Going on in the background are negotiations with large pharmas who wish for anonymity. Large amounts of cash will be flowing Avacta's way just for the initial trials with Affimers and then even larger amounts will be rolling in from licensing agreements once trials have been successful. Of course, not all trials will result in license agreements, but one thing is for sure, Affimers work. The uses for them are almost limitless and Avacta has the potential to make millions of pounds and us shareholders pretty rich. So I'm using the low SP as a buying opportunity and when investors and the MMs wake up to the massive potential and the almost certain success of this company I don't think that the SP will be where it is for much longer. Having said that, there are never any absolute certainties in investing, but Avacta is as near as you will get to one. There will be an update in January from Avacta. I have no idea what it will contain, but I'm certainly looking forward to it.
Trader4Pay
Posts: 57
Off Topic
Opinion:No Opinion
Price:72.00
Price action
13 Dec '16
no seller made a profit today so why sell. well I think today was an example of forced selling and stops got hit or investors getting nervous and probably selling on the lows. Capitulation before a reverse of trend? Do need some positive news here though
Wisheyedbortum
Posts: 635
Observation
Opinion:Hold
Price:70.50
Avacta.
13 Dec '16
I think that the major problem for Avacta now is choosing which partners to grant licences to. There is no point in appointing partners that are not going to take Affimers to commercialization. I hope to find out more soon.
Trader4Pay
Posts: 57
Off Topic
Opinion:No Opinion
Price:76.00
Interview: avacta
13 Dec '16
The pharmaletter have an interview with Alistair. Head line Avacta has advanced beyond the event horizon with Affirmed technology. I don't have a subscription so did not read. Be nice if the SP can escape the event horizon lol. Ur patience is a virtue
sukithedog
Posts: 835
Off Topic
Opinion:Hold
Price:80.00
thats why we dropped
5 Dec '16
30-Nov-1610:27:28 75.00 261,400 Sell* 78.00 82.00 196.05kO
sukithedog
Posts: 835
Off Topic
Opinion:No Opinion
Price:80.00
RE: Drop
30 Nov '16
maybe someone had to sell for a number of reasons , needed the monies , margin call




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.